Prognostic Impact of Bone Mineral Density Reduction During Neoadjuvant Chemotherapy (NAC) in Patients Undergoing NAC Followed by Esophagectomy for Esophageal Cancer
BMD reduction during NAC was considered to be an adverse prognostic factor for OS and RFS in patients underwent NAC followed by esophagectomy for ESCC.
Authors
- Yuichiro Tanishima (ORCID: https://orcid.org/0000-0003-3040-5992)
- Keita Takahashi (ORCID: https://orcid.org/0000-0003-0149-3401)
- Kazuhide Sato
- Masami Yuda (ORCID: https://orcid.org/0000-0001-6132-8585)
- Ken Eto (ORCID: https://orcid.org/0000-0002-3628-4493)
- Takanori Kurogochi (ORCID: https://orcid.org/0000-0002-2188-0444)
- Yoshitaka Ishikawa (ORCID: https://orcid.org/0000-0001-6258-525X)
- Fumiaki Yano (ORCID: https://orcid.org/0000-0001-6682-4166)
- Kazuto Tsuboi (ORCID: https://orcid.org/0000-0002-8126-431X)
- Takahiro Masuda (ORCID: https://orcid.org/0000-0002-6893-7188)
- Naoko Fukushima (ORCID: https://orcid.org/0000-0002-7656-3198)
- Akira Matsumoto
Institutions
- Jikei University School of Medicine (JP)
Publication Details
- Journal
- Annals of Gastroenterological Surgery
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1002/ags3.70025
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00